 |
市場調査レポート
研究用抗体の世界市場予測 2022年：ウエスタンブロッティング・フローケミストリー・ELISA・免疫組織化学法・免疫蛍光法 (IF) ・免疫沈降法Research Antibodies Market by Product (Antibodies (Primary, Secondary)(Mouse, Rabbit)), Reagents), Technology (Western Blot, Flow Cytometry, Elisa, Immunofluorescence, Immunohistochemistry), Application, & End User - Global Forecast to 2022 |
||||||
| 発行 | MarketsandMarkets | 商品コード | 541252 | ||||
| 出版日 | ページ情報 | 英文 281 Pages  |
|||||
| 価格 |
|
||||||
| 研究用抗体の世界市場予測 2022年：ウエスタンブロッティング・フローケミストリー・ELISA・免疫組織化学法・免疫蛍光法 (IF) ・免疫沈降法 Research Antibodies Market by Product (Antibodies (Primary, Secondary)(Mouse, Rabbit)), Reagents), Technology (Western Blot, Flow Cytometry, Elisa, Immunofluorescence, Immunohistochemistry), Application, & End User - Global Forecast to 2022 | ||
| 出版日: 2017年08月07日 | ページ情報: 英文 281 Pages |
|
研究用抗体 (試薬含む) の市場規模は、2017年から2022年にかけて6.2%のCAGR (年間複合成長率) で成長し、2017年の93億3,000万米ドルから2022年までに126億米ドルに達すると予測されています。ライフサイエンス産業におけるR&D活動・支出の増加、プロテオミクス研究&創薬への資金増加、および産学連携の増加は、予測期間中の市場成長に貢献する主な要因となっています。しかし、研究用抗体に対する品質の懸念、コスト・時間のかかる抗体開発プロセス、および有望企業が直面する価格圧力は、研究用抗体・試薬市場の大きな課題となっています。
当レポートでは、研究用抗体・試薬の世界市場に注目し、最新の動向、R&D活動、および新製品発売の動向、製品・技術・アプリケーション・エンドユーザー・地域別による収益性の高い新興市場に関する包括的な情報、および主要企業のプロファイルなどについて、まとめています。
"The global research antibodies market (including reagents) is projected to grow at a CAGR of 6.2%."
The research antibodies market (including reagents) is estimated to grow at a CAGR of 6.2% from 2017 to 2022, to reach USD 12.60 billion by 2022 from USD 9.33 billion in 2017. The increasing R&D activities and expenditure in the life science industry, increasing funding for proteomics research & drug discovery, and growing collaboration between industries and academic institutes are the major factors responsible for the growth of the market during the forecast period. However, the quality concerns over research antibodies (with respect to research reproducibility), cost- and time- intensive antibody development processes, and the pricing pressures faced by prominent market players are the major challenges currently at play in the market.
By product, the research antibodies market (including reagents) is segmented into antibodies and reagents. The research antibodies segment is expected to register the highest CAGR during the forecast period owing to their high sensitivity, specificity, and affinity in various research reactions. Also, they are majorly used in proteomic research and drug development for identification, regulatory characterization, and discovery.
On the basis of end user, the research antibodies market is segmented into pharmaceutical & biotechnological companies, academic & research institutes, and contract research organizations. The pharmaceutical & biotechnological companies segment is expected to grow at the highest CAGR during the forecast period. This is primarily due to the increasing research in the fields of genomics and proteomics and the high uptake of research-specific antibodies in the drug discovery and development process.
Geographically, the global research antibodies market is segmented into North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa. In 2016, North America commanded a major share of the research antibodies market. However, Asia-Pacific is expected to witness the highest growth during the forecast period. The significant growth of the Asia-Pacific market is mainly attributed to the growing proteomics and genomics research & increasing research funding, increasing investments by pharmaceutical and biotechnology companies, and growing awareness of personalized therapeutics.
Some of the prominent players in the research antibodies and reagents market include Thermo Fisher Scientific, Inc. (U.S.), Merck Group (Germany), Abcam plc (U.K.), Becton, Dickinson and Company (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Cell Signaling Technology, Inc. (U.S.), Agilent Technologies, Inc. (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), Danaher Corporation (U.S.), GenScript (U.S.), PerkinElmer, Inc. (U.S.), Lonza (Switzerland), and BioLegend, Inc. (U.S.).
The report analyzes the various types of research antibodies and reagents in the market and their adoption patterns. It aims at estimating the market size and future growth potential of the research antibodies market for different segments such as product, technology, application, end user, and region. The report also includes an in-depth competitive analysis of the key players in this market along with their company profiles, product offerings, recent developments, and market strategies.
The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help firms in garnering a greater market share. Firms purchasing the report could use any one or combination of the below-mentioned five strategies for strengthening their market position.
The report provides insights on the following pointers:
*Details on Overview, Strength of Product Portfolio, Business Strategy Excellence, Products Offering, and Recent Developments might not be captured in case of unlisted companies.
